CCMINC
REGN icon

Cardinal Capital Management Inc (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Sell
8,397
-39
-0.5% -$26.5K 0.63% 50
2026
Q1 		$6.52M Buy
8,436
+30
+0.4% +$23K 0.84% 41
2025
Q4 		$6.49M Sell
8,406
-25
-0.3% -$17K 0.86% 41
2025
Q3 		$4.74M Buy
8,431
+115
+1% +$65K 0.66% 52
2025
Q2 		$4.37M Buy
8,316
+280
+3% +$156K 0.64% 52
2025
Q1 		$5.1M Buy
8,036
+165
+2% +$113K 0.79% 43
2024
Q4 		$5.61M Buy
7,871
+36
+0.5% +$30.2K 0.88% 39
2024
Q3 		$8.24M Buy
7,835
+45
+0.6% +$50.1K 1.28% 25
2024
Q2 		$8.19M Buy
7,790
+16
+0.2% +$15.5K 1.38% 23
2024
Q1 		$7.48M Buy
7,774
+284
+4% +$270K 1.22% 27
2023
Q4 		$6.58M Sell
7,490
-16
-0.2% -$13.2K 1.25% 32
2023
Q3 		$6.18M Buy
7,506
+88
+1% +$69.2K 1.26% 27
2023
Q2 		$5.33M Buy
7,418
+57
+0.8% +$43.9K 1.07% 36
2023
Q1 		$6.05M Sell
7,361
-55
-0.7% -$41.5K 1.25% 30
2022
Q4 		$5.35M Sell
7,416
-46
-0.6% -$33.9K 1.14% 32
2022
Q3 		$5.14M Buy
7,462
+68
+0.9% +$42.8K 1.22% 28
2022
Q2 		$4.37M Buy
7,394
+30
+0.4% +$19.5K 1% 41
2022
Q1 		$5.14M Buy
7,364
+130
+2% +$82.2K 1.04% 35
2021
Q4 		$4.57M Sell
7,234
-22
-0.3% -$13.5K 0.9% 41
2021
Q3 		$4.39M Sell
7,256
-83
-1% -$51.5K 0.95% 39
2021
Q2 		$4.1M Sell
7,339
-25
-0.3% -$12.7K 0.87% 42
2021
Q1 		$3.48M Buy
7,364
+96
+1% +$46.7K 0.77% 44
2020
Q4 		$3.51M Buy
7,268
+66
+0.9% +$35.6K 0.83% 45
2020
Q3 		$4.03M Sell
7,202
-7
-0.1% -$4.24K 1.11% 35
2020
Q2 		$4.5M Sell
7,209
-29
-0.4% -$16.5K 1.29% 31
2020
Q1 		$3.53M Buy
7,238
+299
+4% +$123K 1.17% 38
2019
Q4 		$2.6M Buy
+6,939
New +$2.33M 0.68% 49

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s REGN Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) reduced its Regeneron Pharmaceuticals (REGN) stake by 0.46% in Q2 2026, selling an estimated $26.5K and leaving 8,397 shares worth $5.24M. The position accounts for 0.63% of the portfolio, ranked #50.

Cardinal Capital Management Inc (North Carolina) first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.24M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 8,397 shares of Regeneron Pharmaceuticals worth $5.24M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) sold 39 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $26.5K.
  • Regeneron Pharmaceuticals made up 0.63% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #50 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Regeneron Pharmaceuticals position peaked at $8.24M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.